Recombinant PD-L1 anticorps
Aperçu rapide pour Recombinant PD-L1 anticorps (ABIN7127670)
Antigène
Voir toutes PD-L1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- CD274 Recombinant Monoclonal Antibody
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human PD-L1 (CD274)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:5000, IHC:1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- CD274
-
Sujet
-
Background: Involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production.
Aliases: Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (B7 homolog 1) (B7-H1) (CD antigen CD274), CD274, B7H1 PDCD1L1 PDCD1LG1 PDL1
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-